Sustained eradication of hepatitis C virus by low-dose long-term interferon therapy in a renal transplant recipient with dual infection with hepatitis B and C viruses: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Chang, Ming Ling ^a,b   Lai, Ping Chin ^a   Yeh, Chau Ting ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; LAMIVUDINE; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; ERADICATION THERAPY; FATTY LIVER; FOLLOW UP; GENOTYPE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER BIOPSY; LIVER FIBROSIS; LOW DRUG DOSE; MALE; MIXED INFECTION; PRIORITY JOURNAL; VIRUS REACTIVATION;

EID: 79959636998     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-246     Document Type: Article

References (14)

1. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. TJ Liang T Heller, Gastroenterology 2004 127 5 Suppl 1 62 S71 15508105
2. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. NA Terrault DB Adey, Clin J Am Soc Nephrol 2007 2 563 575 10.2215/CJN.02930806 17699464
3. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. JM Morales J Pascual-Capdevila JM Campistol G Fernandez-Zatarain MA Mũoz A Andres M Praga MA Martinez G Usera A Fuertes F Oppenheimer P Artal A Darnell JL Rodicio, Transplantation 1997 63 1634 1639 10.1097/00007890-199706150-00017 9197359 (Pubitemid 27265507)
4. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon- therapy. CM Toth M Pascual RT Chung F Graeme-Cook JL Dienstag AK Bhan AB Cosimi, Transplantation 1998 66 1254 1258 10.1097/00007890-199811150-00023 9825826 (Pubitemid 28530333)
5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. RK Sharma SB Bansal A Gupta S Gulati A Kumar N Prasad, Clin Transplant 2006 20 677 683 10.1111/j.1399-0012.2006.00534.x 17100715 (Pubitemid 44712266)
6. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation? TH Yen CC Huang HH Lin JY Huang YC Tian CW Yang MS Wu JT Fang CC Yu YJ Chiang SH Chu, Nephrol Dial Transplant 2006 21 1046 1052 16390851
7. Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study. DA Freshwater T Dudley P Cane DJ Mutimer, Transplantation 2008 85 1105 1111 10.1097/TP.0b013e31816a342a 18431229 (Pubitemid 351590187)
8. Hepatocellular carcinoma and hepatitis C in the United States. HB El-Serag, Hepatology 2002 36 5 Suppl 1 74 S83 12407579
9. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. JM Matthews-Greer GC Caldito SD Adley R Willis AC Mire RM Jamison KL McRae JW King WL Chang, Clin Diagn Lab Immunol 2001 8 690 694 11427412 (Pubitemid 32613692)
10. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin. N Bräu, Semin Liver Dis 2005 25 33 51 10.1055/s-2005-864780 15731996 (Pubitemid 40322349)
11. Ultralow-dose -interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients. KH Shu JL Lan MJ Wu CH Cheng CH Chen WC Lee HR Chang JD Lian, Transplantation 2004 77 1894 1896 10.1097/01.TP. 0000131151.07818.D7 15223909
12. Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interferon- therapy. I Konishi N Horiike K Michitaka N Ochi S Furukawa H Minami M Onji, Intern Med 2004 43 931 934 10.2169/internalmedicine.43.931 15575242 (Pubitemid 39534796)
13. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. ML Shiffman CM Hofmann MJ Contos VA Luketic AJ Sanyal RK Sterling A Ferreira-Gonzalez AS Mills C Garret, Gastroenterology 1999 117 1164 1172 10.1016/S0016-5085(99)70402-6 10535880 (Pubitemid 29512676)
14. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial. L Alric M Duffaut J Selves K Sandre M Mularczyck J Izopet H Desmorat C Bureau N Chaouche B Dalbergue JP Vinel, J Hepatol 2001 35 272 278 10.1016/S0168-8278(01)00110-6 11580151 (Pubitemid 32803484)